Ameritas Advisory Services’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Sell
886
-471
-35% -$97.9K ﹤0.01% 1076
2026
Q1
$287K Buy
1,357
+314
+30% +$67.6K 0.01% 786
2025
Q4
$214K Buy
1,043
+858
+464% +$161K 0.01% 878
2025
Q3
$29.1K Sell
185
-441
-70% -$68.1K ﹤0.01% 1298
2025
Q2
$105K Buy
+626
New +$92.9K 0.01% 971
2023
Q2
Sell
-1,332
Closed -$102K 830
2023
Q1
$102K Buy
+1,332
New +$100K 0.01% 995

Other funds holding CAH

Ameritas Advisory Services's CAH Position: Q2 2026 in Review

Ameritas Advisory Services reduced its Cardinal Health (CAH) stake by 35% in Q2 2026, selling an estimated $97.9K and leaving 886 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Ameritas Advisory Services first reported a position in CAH in Q1 2023 and has held it in 6 quarters since. The position peaked at $287K in Q1 2026. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Ameritas Advisory Services held 886 shares of Cardinal Health worth $210K as of Q2 2026.
  • Ameritas Advisory Services sold 471 Cardinal Health shares in Q2 2026, an estimated $97.9K.
  • Cardinal Health made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1076 holding.
  • Ameritas Advisory Services first reported a position in Cardinal Health in Q1 2023 and has held it in 6 quarters since.
  • Ameritas Advisory Services's Cardinal Health position peaked at $287K in Q1 2026.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.